COCOA, Brazil (Reuters) – Brazilian cosmetics giant Colna has announced plans to roll out an anti-aging serum, the first of its kind to be sold in the United States, the UK and Canada.

The company said on Thursday it will start selling a “coconut cream” which it said will “improve skin tone, tone and prevent age-related problems”.

“Our goal is to help people get more youthful,” said the company in a statement.

The product is due to be available on Colna’s website for $19 a bottle in the US, and $26 a bottle for the rest of the world.

The Colna website did not list an estimated retail price.

The first anti-ageing serum is one of the first such products to hit the market in the world, with China and Japan already making it available.

Colna, which is owned by China’s Zhejiang Geely Holding Co Ltd, plans to sell the coconut cream on its website in the next two months, and in stores around the world within six months.

Colnada said it had raised $30 million in funding last year, bringing its total funds raised to $55 million since it launched its first product in 2011.

Colana is part of Colna-owned pharmaceutical company AstraZeneca, which makes corticosteroids.

Its shares fell as much as 4.8 percent on Thursday.